And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is particularly modest. We plan to catch up on our reading and napping, hang with a short person or two, and perhaps putter around the castle. And what about you? Now that spring is here, this may be an opportunity to plan a needed break. You could make time for someone special. Adventurous Anglophiles can amuse themselves betting on the Brexit outcome. Or you could simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Nearly 8,000 packets of a Vertex Pharmaceuticals (VRTX) cystic fibrosis drug were destroyed last year while the company and the National Health Service in England haggled over price, The Independent reports. Documents released by the House of Commons Health Committee show that 7,880 packets, each offering a 28-day supply of the drug and intended for distribution around Europe, exceeded their expiry date in 2018. This would be enough to provide the drug for around three months to every one of the 2,834 eligible patients in England.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • It would seem Commissioner G has interests that will, again, possibly continue long past his imminent departure. (Until, of course, they get tweeted down … not that he has seen much of that.) May I observe that we shall miss him, whether for good or ill? “Leich l’shalom,” Scott Gottlieb, MD….

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy